Skip to main content

Can I drink alcohol while taking Entyvio?

Medically reviewed by Sally Chao, MD. Last updated on Sep 21, 2023.

Official answer

by Drugs.com

Although there is no indication that alcohol and Entyvio (vedolizumab) have unsafe interactions, you should ask your doctor before drinking alcohol while taking Entyvio. Research has not been conducted to look explicitly at the safety of combining alcohol and Entyvio.

In rare cases, Entyvio is known to cause liver problems, which could be heightened by alcohol consumption.

Drinking alcohol may also affect your symptoms of Crohn’s disease or ulcerative colitis. Both of these conditions are types of inflammatory bowel disease. While research on this topic is mixed, there is some indication that alcohol consumption may worsen symptoms of inflammatory bowel disease.

References
  1. Takeda Pharmaceuticals U.S.A., Inc. Entyvio: Questions & Answers. 2020. Available at: https://www.entyvio.com/frequently-asked-questions. [Accessed August 27, 2021].
  2. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Vedolizumab. Available at: https://europepmc.org/article/MED/31644050. [Accessed August 27, 2021].
  3. U.S. Department of Health & Human Services: Office on Women’s Health. Inflammatory Bowel Disease. April 1, 2019. Available at: https://www.womenshealth.gov/a-z-topics/inflammatory-bowel-disease. [Accessed August 27, 2021].
  4. Swanson GR, Sedghi S, Farhadi A, Keshavarzian A. Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol. 2010;44(3):223-228. doi: 10.1016/j.alcohol.2009.10.019.

Read next

The cash price for Entyvio is $9,135 for a 300 mg powder for intravenous (IV) injection, using an online coupon, but most people do not pay this amount. After your initial 2 injections in the first month, IV Enytvio is normally given every 8 weeks starting at week 6. It also comes as a subcutaneous (under the skin) injection that is given every 2 weeks. Continue reading

Entyvio (generic name: vedolizumab) is a biologic therapy approved for the treatment of ulcerative colitis and Crohn’s disease. Entyvio has no known systemic (whole body) immunosuppressive effects, but still has a risk of infections. Continue reading

Entyvio may reduce your gut inflammation in about 6 weeks. Over time, Entyvio can help you to have fewer symptoms, go into remission, and reduce or stop the use of corticosteroids. In remission, your symptoms such as stomach pain and cramping, diarrhea and fatigue will go away. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer